Good news for men—potentially—but bad news for patent librarians.
Millennium Predictive Medicine of Massachusetts has filed a patent (WO 01/60860)
on “novel genes” for identifying, assessing, preventing and treating prostate
cancer. It says the genes change as a patient develops prostate cancer, and so
provide an early warning of the disease. This should improve the chances for
therapy or surgery. But the gene sequences are so long that the patent fills 14
box files—equivalent to several hundred conventional paper patents.
More from New Scientist
Explore the latest news, articles and features
Technology
Test moderators use AI-generated writing to judge literacy standards
News
Technology
We should decide how AI shapes the future, not tech firms
Comment
Technology
Quantum voting could make elections more secure
News
Technology
DeepMind AI gives an extra day of warning ahead of deadly cyclones
News
Popular articles
Trending New Scientist articles